ArticleJournal of nanobiotechnology2025
Correction: Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.
Wanyue Cao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.